(₹ crores) | Q1FY26 | Q4FY25 | Q1FY25 | QoQ (%) | YoY (%) |
---|---|---|---|---|---|
Total Income | 73.49 | 56.17 | 61.85 | 30.8% | 18.8% |
Total Expenses | 61.91 | 46.16 | 51.34 | 34.1% | 20.6% |
Profit Before Tax | 12.47 | 9.23 | 10.51 | 35.1% | 18.6% |
Tax | 3.29 | 2.91 | 2.85 | 13.1% | 15.4% |
Profit After Tax | 9.18 | 6.32 | 7.67 | 45.3% | 19.7% |
Earnings Per Share | 1.80 | 0.00 | 1.50 | - | 20.0% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Suraksha Diagnostic Ltd is a company operating in the healthcare sector, primarily focusing on diagnostic services. The company provides a wide range of diagnostic tests including pathology and imaging services. As of the latest information available up to October 2023, Suraksha Diagnostic Ltd is noted for its commitment to quality and accuracy in medical diagnostics. However, specific major recent developments or expansions in its operations are not available within the provided data. The company continues to serve a critical role in healthcare, offering essential diagnostic services that support the medical needs of individuals.
In Q1FY26, Suraksha Diagnostic Ltd reported a total income of ₹73.49 crores, marking a significant increase from the ₹56.17 crores recorded in the previous quarter, Q4FY25. This represents a quarter-over-quarter (QoQ) growth of 30.8%. Comparing year-over-year (YoY) performance, the total income increased by 18.8% from ₹61.85 crores in Q1FY25 to ₹73.49 crores in Q1FY26. These figures highlight a notable upward trajectory in revenue generation over both the quarterly and annual periods, reflecting the company’s capacity to enhance its income streams.
The profitability metrics for Suraksha Diagnostic Ltd in Q1FY26 indicate a positive trend. The profit before tax (PBT) for the quarter stood at ₹12.47 crores, up from ₹9.23 crores in Q4FY25, reflecting a QoQ increase of 35.1%. Year-over-year, the PBT rose by 18.6% from ₹10.51 crores in Q1FY25. The company's tax expenses in Q1FY26 were ₹3.29 crores, showing a modest QoQ increase of 13.1% and a YoY rise of 15.4%. After accounting for taxes, the profit after tax (PAT) for Q1FY26 was ₹9.18 crores, which is a 45.3% QoQ increase from ₹6.32 crores in Q4FY25, and a 19.7% YoY increase from ₹7.67 crores in Q1FY25. These profitability figures underscore a strong performance in generating profit over both comparative periods.
The company's operational performance is further illustrated by its Earnings Per Share (EPS), which was ₹1.80 in Q1FY26. This reflects a 20.0% increase compared to the ₹1.50 reported in Q1FY25. However, no EPS was reported for Q4FY25, which might indicate adjustments or restatements in financial reporting practices. The total expenses for Q1FY26 were ₹61.91 crores, representing a QoQ increase of 34.1% from ₹46.16 crores in Q4FY25, and a YoY rise of 20.6% from ₹51.34 crores in Q1FY25. These figures suggest that while expenses have risen, the company has managed to maintain profitability and growth in its key financial metrics.
Suraksha Diagnostic Ltd announced its Q1 FY 2025-26 results on 9 August, 2025.
Suraksha Diagnostic Ltd quarterly results refer to the company’s financial performance over a three-month period, including key metrics like revenue, net profit, earnings per share (EPS), and margin performance.
Key highlights of Suraksha Diagnostic Ltd Q1 FY 2025-26 results include:
Suraksha Diagnostic Ltd reported a net profit of ₹9.18 crore in Q1 FY 2025-26, reflecting a 19.7% year-over-year growth.
Suraksha Diagnostic Ltd posted a revenue of ₹73.49 crore in Q1 FY 2025-26.